AvaloTx

avalotx.com

Financial Services

Biotechnology

Health Care

As featured in

Yahoo Finance

Claim pageClaim

Overview

Connections

News

Salaries

Products

People

Growth

Offices

Financials

Overview

One vision. Working to transform lives through the development of innovative therapies targeting the IL-1β pathway At Avalo, we're focused on developing treatments for immune-mediated inflammatory diseases with large unmet needs that affect millions worldwide.

Connections

List

Graph

Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.

Shared investors3

Horizon Technology FinanceVia a fund

153 portfolio companies: New York Stock Exchange - An Ice Exchange, Small Business Investor Alliance, DIANA STUTZ DESIGN and 150 more

OrbiMedVia a fund

196 portfolio companies: Cookiedatabase.org, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., Z-Alpha Therapeutics and 193 more

NEAVia a fund

673 portfolio companies

Report a mistake

News

News YahooFinance 1 month ago

Avalo Therapeutics to Participate in Upcoming Investor Conferences

WAYNE, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that

Report